Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frits Koning

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
EFSA Journal. European Food Safety Authority|May 14, 2025
Assessment of genetically modified oilseed rape MON 88302 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21220), Josep Casacuberta, Francisco Barro, et al.
Haematologica|January 29, 2026
Selective lymphodepletion underlies the efficacy of horse anti-thymocyte globulin-based immunosuppressive therapy in aplastic anemiaEmma S Pool, Cilia R Pothast, Shannah M Gennesse, et al.
World Journal of Gastroenterology|October 15, 2013
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-studyGreetje J Tack, Jolanda M W van de Water, Maaike J Bruins, et al.
EFSA Journal. European Food Safety Authority|July 6, 2026
Assessment of genetically modified soybean FG72 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2025-33580), Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority|August 11, 2025
Assessment of genetically modified T25 maize for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2024-22651), Josep Casacuberta, Francisco Barro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2017
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytesYvonne M C Kooy-Winkelaar, Dagmar Bouwer, George M C Janssen, et al.
EFSA Journal. European Food Safety Authority|July 23, 2025
Assessment of genetically modified cotton T304-40 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2024-23010), Josep Casacuberta, Francisco Barro, et al.
BMC Genomics|January 13, 2006
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopesTeun W J M van Herpen, Svetlana V Goryunova, Johanna van der Schoot, et al.
Frontiers in Genetics|February 11, 2021
Systematic Prioritization of Candidate Genes in Disease Loci Identifies <i>TRAFD1</i> as a Master Regulator of IFNγ Signaling in Celiac DiseaseAdriaan van der Graaf, Maria M Zorro, Annique Claringbould, et al.
Nature Structural & Molecular Biology|April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseJan Petersen, Veronica Montserrat, Jorge R Mujico, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
EFSA Journal. European Food Safety Authority|May 14, 2025
Assessment of genetically modified oilseed rape MON 88302 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2023-21220), Josep Casacuberta, Francisco Barro, et al.
Haematologica|January 29, 2026
Selective lymphodepletion underlies the efficacy of horse anti-thymocyte globulin-based immunosuppressive therapy in aplastic anemiaEmma S Pool, Cilia R Pothast, Shannah M Gennesse, et al.
World Journal of Gastroenterology|October 15, 2013
Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-studyGreetje J Tack, Jolanda M W van de Water, Maaike J Bruins, et al.
EFSA Journal. European Food Safety Authority|July 6, 2026
Assessment of genetically modified soybean FG72 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2025-33580), Josep Casacuberta, Francisco Barro, et al.
EFSA Journal. European Food Safety Authority|August 11, 2025
Assessment of genetically modified T25 maize for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2024-22651), Josep Casacuberta, Francisco Barro, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 5, 2017
CD4 T-cell cytokines synergize to induce proliferation of malignant and nonmalignant innate intraepithelial lymphocytesYvonne M C Kooy-Winkelaar, Dagmar Bouwer, George M C Janssen, et al.
EFSA Journal. European Food Safety Authority|July 23, 2025
Assessment of genetically modified cotton T304-40 for renewal authorisation under Regulation (EC) No 1829/2003 (dossier GMFF-2024-23010), Josep Casacuberta, Francisco Barro, et al.
BMC Genomics|January 13, 2006
Alpha-gliadin genes from the A, B, and D genomes of wheat contain different sets of celiac disease epitopesTeun W J M van Herpen, Svetlana V Goryunova, Johanna van der Schoot, et al.
Frontiers in Genetics|February 11, 2021
Systematic Prioritization of Candidate Genes in Disease Loci Identifies <i>TRAFD1</i> as a Master Regulator of IFNγ Signaling in Celiac DiseaseAdriaan van der Graaf, Maria M Zorro, Annique Claringbould, et al.
Nature Structural & Molecular Biology|April 30, 2014
T-cell receptor recognition of HLA-DQ2-gliadin complexes associated with celiac diseaseJan Petersen, Veronica Montserrat, Jorge R Mujico, et al.
Pageof 20